Olivia Fletcher

20.9k total citations · 1 hit paper
51 papers, 2.8k citations indexed

About

Olivia Fletcher is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Olivia Fletcher has authored 51 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 23 papers in Genetics and 11 papers in Oncology. Recurrent topics in Olivia Fletcher's work include BRCA gene mutations in cancer (12 papers), Genetic Associations and Epidemiology (9 papers) and Epigenetics and DNA Methylation (8 papers). Olivia Fletcher is often cited by papers focused on BRCA gene mutations in cancer (12 papers), Genetic Associations and Epidemiology (9 papers) and Epigenetics and DNA Methylation (8 papers). Olivia Fletcher collaborates with scholars based in United Kingdom, United States and France. Olivia Fletcher's co-authors include Julian Peto, Clare Gilham, Fiona E. Matthews, Richard S. Houlston, Nichola Johnson, Isabel dos‐Santos‐Silva, Frank Dudbridge, Julian Peto, Alan Ashworth and Anna M. Kessling and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Olivia Fletcher

51 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The cervical cancer epidemic that screening has prevented in the UK

2004 598 citations Julian Peto, Clare Gilham et al. The Lancet profile →

Peers

Countries citing papers authored by Olivia Fletcher

Since Specialization

Citations

This map shows the geographic impact of Olivia Fletcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivia Fletcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivia Fletcher more than expected).

Fields of papers citing papers by Olivia Fletcher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivia Fletcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivia Fletcher. The network helps show where Olivia Fletcher may publish in the future.

Co-authorship network of co-authors of Olivia Fletcher

This figure shows the co-authorship network connecting the top 25 collaborators of Olivia Fletcher. A scholar is included among the top collaborators of Olivia Fletcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivia Fletcher. Olivia Fletcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	‘Friendly’ and ‘noisy surveillance’ through MapMyRun during the COVID-19 pandemic 2022 ·Geoforum ·Olivia Fletcher	11
2	Identifying high-confidence capture Hi-C interactions using CHiCANE 2021 ·Nature Protocols ·Erle M. Holgersen, Andrea Gillespie, Olivia C. Leavy, (unknown), (unknown), Gareth Muirhead, Nichola Johnson, (unknown), Nicola H. Dryden, (unknown), Yi Chen, Igor Kozine, Frank Dudbridge, Olivia Fletcher, Syed Haider	11
3	DNA methylation of the long intergenic noncoding RNA 299 gene in triple-negative breast cancer: results from a prospective study 2020 ·Scientific Reports ·(unknown), Michael E. Jones, Katarzyna Tomczyk, Olivia Fletcher, Minouk J. Schoemaker, Anthony J. Swerdlow, (unknown), Ute Hamann	10
4	Capture Hi-C identifies putative target genes at 33 breast cancer risk loci 2018 ·Nature Communications ·(unknown), Olivia C. Leavy, Nicola H. Dryden, Sarah Maguire, Nichola Johnson, Vita Fedele, Nikiana Simigdala, Lesley‐Ann Martin, Simon Andrews, Steven Wingett, Ioannis Assiotis, Kerry Fenwick, Ritika Chauhan, Alistair G. Rust, Nick Orr, Frank Dudbridge, Syed Haider, Olivia Fletcher	72
5	Mitochondrial DNA Copy Number in Peripheral Blood Cells and Risk of Developing Breast Cancer 2015 ·Cancer Research ·(unknown), Mark N. Brook, Olivia Fletcher, Penny Coulson, Katarzyna Tomczyk, Michael E. Jones, Alan Ashworth, Anthony J. Swerdlow, Nick Orr, Montserrat García‐Closas	43
6	Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study 2014 ·Cancer Epidemiology Biomarkers & Prevention ·James M. Flanagan, Mark N. Brook, Nick Orr, Katarzyna Tomczyk, Penny Coulson, Olivia Fletcher, Michael E. Jones, Minouk J. Schoemaker, Alan Ashworth, Anthony J. Swerdlow, Robert Brown, Montserrat García‐Closas	47
7	Unbiased analysis of potential targets of breast cancer susceptibility loci by Capture Hi-C 2014 ·Genome Research ·Nicola H. Dryden, (unknown), Frank Dudbridge, Nichola Johnson, Nick Orr, Stefan Schoenfelder, Takashi Nagano, Simon Andrews, Steven Wingett, Iwanka Kozarewa, Ioannis Assiotis, Kerry Fenwick, Sarah Maguire, James Campbell, Rachael Natrajan, Maryou Lambros, (unknown), Alan Ashworth, Peter Fraser, Olivia Fletcher	174
8	Intragenic ATM Methylation in Peripheral Blood DNA as a Biomarker of Breast Cancer Risk 2012 ·Cancer Research ·Kevin Brennan, Montserrat García‐Closas, Nick Orr, Olivia Fletcher, Michael E. Jones, Alan Ashworth, Anthony J. Swerdlow, Heather Thorne, Elio Ríboli, Paolo Vineis, Miren Dorronsoro, Françoise Clavel‐Chapelon, Salvatore Panico, N. Charlotte Onland‐Moret, Dimitrios Trichopoulos, Rudolf Kaaks, Kay‐Tee Khaw, Robert Brown, James M. Flanagan	118
9	The influence of formulation and medicine delivery system on medication administration errors in care homes for older people 2011 ·BMJ Quality & Safety ·David P Alldred, Claire Standage, Olivia Fletcher, Imogen Savage, James R. Carpenter, Nicholas Barber, David K. Raynor	31
10	Genetic Variants at Chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 Influence the Risk of Breast Cancer in Men 2011 ·PLoS Genetics ·Nick Orr, Rosie Cooke, Michael E. Jones, Olivia Fletcher, Frank Dudbridge, (unknown), Katarzyna Tomczyk, Peter Broderick, Richard S. Houlston, Alan Ashworth, Anthony J. Swerdlow	24
11	Effect of a Nutrition Supplement and Physical Activity Program on Pneumonia and Walking Capacity in Chilean Older People: A Factorial Cluster Randomized Trial 2011 ·PLoS Medicine ·Alan D. Dangour, Cecilia Albala, Elizabeth Allen, Emily Grundy, Damian Walker, Cristián Aedo, Hugo Sánchez, Olivia Fletcher, Diana Elbourne, Ricardo Uauy	41
12	Architecture of inherited susceptibility to common cancer 2010 ·Nature reviews. Cancer ·Olivia Fletcher, Richard S. Houlston	140
13	Premenopausal Mammographic Density in Relation to Cyclic Variations in Endogenous Sex Hormone Levels, Prolactin, and Insulin-like Growth Factors 2009 ·Cancer Research ·Kate Walker, Olivia Fletcher, Nichola Johnson, Ben Coupland, Valerie McCormack, Elizabeth Folkerd, Lorna J. Gibson, Stephen G. Hillier, Jeff M.P. Holly, Sue Moss, Mitch Dowsett, Julian Peto, Isabel dos‐Santos‐Silva	54
14	The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury 2009 ·Trials ·Haleema Shakur‐Still, Peter Andrews, Toomas Asser, Laura Balica, (unknown), (unknown), Yashbir Dewan, Patrick Druwé, Olivia Fletcher, Chris Frost, Bennie Hartzenberg, (unknown), F. Murillo‐Cabezas, Jan Pachl, (unknown), Indrek Rätsep, Cristina Sampaio, Manmohan Singh, Petr Svoboda, Ian Roberts	36
15	Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients 2009 ·Human Molecular Genetics ·James M. Flanagan, (unknown), Stephen Henderson, Thomas Tang, Ping Sun, Nichola Johnson, Olivia Fletcher, Isabel dos‐Santos‐Silva, Julian Peto, Chris Boshoff, Steven A. Narod, Artūras Petronis	107
16	Inconsistent Association Between the STK15 F31I Genetic Polymorphism and Breast Cancer Risk 2006 ·JNCI Journal of the National Cancer Institute ·Olivia Fletcher, Nichola Johnson, Claire Palles, Isabel dos‐Santos‐Silva, Valerie McCormack, John C. Whittaker, Alan Ashworth, Julian Peto	35
17	Interaction between CHEK21100delC and other low-penetrance breast-cancer susceptibility genes: a familial study 2005 ·The Lancet* ·Nichola Johnson, Olivia Fletcher, Cristina Naceur‐Lombardelli, Isabel dos‐Santos‐Silva, Alan Ashworth, Julian Peto	55
18	Lifetime Risks of Common Cancers Among Retinoblastoma Survivors 2004 ·JNCI Journal of the National Cancer Institute ·Olivia Fletcher, Douglas F. Easton, Kristin Anderson, Clare Gilham, Marcelle Jay, Julian Peto	172
19	The cervical cancer epidemic that screening has prevented in the UK breakdown → 2004 ·The Lancet ·Julian Peto, Clare Gilham, Olivia Fletcher, Fiona E. Matthews	598
20	Interpreting information: what is said, what is heard—a questionnaire study of health professionals and members of the public 2002 ·Prenatal Diagnosis ·Lenore Abramsky, Olivia Fletcher	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact